<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id>
<journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id>
<journal-id journal-id-type="publisher-id">OMCL</journal-id>
<journal-title-group>
<journal-title>Oxidative Medicine and Cellular Longevity</journal-title>
</journal-title-group>
<issn pub-type="ppub">1942-0900</issn>
<issn pub-type="epub">1942-0994</issn>
<publisher>
<publisher-name>Hindawi</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31178961</article-id>
<article-id pub-id-type="pmc">6501164</article-id>
<article-id pub-id-type="doi">10.1155/2019/4730539</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Gut Microbiota in Alzheimer's Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-5935-8283</contrib-id>
<name>
<surname>Luca</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-0443-6437</contrib-id>
<name>
<surname>Di Mauro</surname>
<given-names>Maurizio</given-names>
</name>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-0420-5244</contrib-id>
<name>
<surname>Di Mauro</surname>
<given-names>Marco</given-names>
</name>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-8397-3478</contrib-id>
<name>
<surname>Luca</surname>
<given-names>Antonina</given-names>
</name>
<email>antolucaster@gmail.com</email>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="I1">
<sup>1</sup>Department of Medical, Surgical Sciences and Advanced Technologies “GF Ingrassia”, University of Catania, Italy</aff>
<aff id="I2">
<sup>2</sup>Department of Clinical and Experimental Medicine, University of Catania, Italy</aff>
<aff id="I3">
<sup>3</sup>Department of Biomedical and Biotechnological Sciences, University of Catania, Italy</aff>
<author-notes>
<fn fn-type="other">
<p>Academic Editor: Victor M. Victor</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>4</month>
<year>2019</year>
</pub-date>
<volume>2019</volume>
<elocation-id>4730539</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Maria Luca et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Gut microbiota consists of over 100 trillion microorganisms including at least 1000 different species of bacteria and is crucially involved in physiological and pathophysiological processes occurring in the host. An imbalanced gastrointestinal ecosystem (dysbiosis) seems to be a contributor to the development and maintenance of several diseases, such as Alzheimer's disease, depression, and type 2 diabetes mellitus. Interestingly, the three disorders are frequently associated as demonstrated by the high comorbidity rates. In this review, we introduce gut microbiota and its role in both normal and pathological processes; then, we discuss the importance of the gut-brain axis as well as the role of oxidative stress and inflammation as mediators of the pathological processes in which dysbiosis is involved. Specific sections pertain the role of the altered gut microbiota in the pathogenesis of Alzheimer's disease, depression, and type 2 diabetes mellitus. The therapeutic implications of microbiota manipulation are briefly discussed. Finally, a conclusion comments on the possible role of dysbiosis as a common pathogenetic contributor (via oxidative stress and inflammation) shared by the three disorders.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>1. Introduction</title>
<sec id="sec1.1">
<title>1.1. Gut Microbiota</title>
<p>Recent technological advances have increased the interest on the relationship between the microorganisms inhabiting the gut (gut microbiota) and human health. The gastrointestinal tract hosts over 100 trillion microorganisms including at least 1000 different species of bacteria [<xref ref-type="bibr" rid="B1">1</xref>]. In humans, about 1/3 of gut microbiota is “common,” while the other 2/3 is different from one individual to another, providing our “personal identity” [<xref ref-type="bibr" rid="B2">2</xref>]. Despite the difficulties in defining a “good” microbiota, data suggest that, in adulthood, a healthy microbiota is characterized by the community stability and the species diversity. More specifically, despite lifestyle and food changes, the <italic>Firmicutes</italic> (such as Lactobacillus) and the <italic>Bacteroides</italic> represent the main bacterial phyla in the gut [<xref ref-type="bibr" rid="B3">3</xref>] followed by <italic>Proteobacteria</italic>, <italic>Actinobacteria</italic> (such as Bifidobacterium), and <italic>Cyanobacteria</italic> [<xref ref-type="bibr" rid="B2">2</xref>], which constitute an ecological community entertaining a beneficial relationship with the host [<xref ref-type="bibr" rid="B4">4</xref>]. As a result, an imbalance of the intestinal bacteria representation (dysbiosis) could lead to different diseases, ranging from inflammatory bowel disease to obesity, diabetes, and asthma, as well as Parkinson's disease, Alzheimer's disease (AD), and depression [<xref ref-type="bibr" rid="B5">5</xref>].</p>
</sec>
<sec id="sec1.2">
<title>1.2. The Gut-Brain Axis</title>
<p>The term “gut-brain axis” refers to a crosstalk between the brain and the gut involving multiple overlapping pathways, including the autonomic, neuroendocrine, and immune systems as well as bacterial metabolites and neuromodulatory molecules [<xref ref-type="bibr" rid="B6">6</xref>].</p>
<p>In particular, millions of nerves end in the gastrointestinal tract mucosa, constituting the enteric nervous system which regulates the intestinal functions and communicates with the brain through the vagus nerve. The latter is responsible for the transmission of signals from the brain to the gastrointestinal tract (through the autonomic nervous system) and vice versa [<xref ref-type="bibr" rid="B7">7</xref>]. The presence of dysbiosis, causing the breakdown of the intestinal permeability, can lead to an inflammatory condition not limited to the gut, since the proinflammatory cytokines can get into the bloodstream and reach the brain [<xref ref-type="bibr" rid="B8">8</xref>]. The importance of inflammation should not be underestimated, since several evidences support its crucial role in several chronic disorders, such as type 2 diabetes [<xref ref-type="bibr" rid="B9">9</xref>], AD [<xref ref-type="bibr" rid="B10">10</xref>], and depression [<xref ref-type="bibr" rid="B11">11</xref>]. Apart from the cytokines, other mediators can send signals from the gut to the brain through the vagus nerve. In fact, especially after a meal rich of fats and carbohydrates, a subgroup of specialized intestinal cells, named enteroendocrine cells, releases hormones and peptides, such as 5-hydroxitryptamine (5-HT), cholecystokinin (CKK), glucagon-like peptide-1 (GLP-1), and peptide YY (PYY) [<xref ref-type="bibr" rid="B12">12</xref>]. These mediators exert many important functions. For example, PYY and GLP-1 inhibit the intestinal peristalsis and improve glucose metabolism attenuating pancreatic islet hypertrophy and the insulin resistance [<xref ref-type="bibr" rid="B13">13</xref>]. Moreover, these peptides, binding their cognate receptors located in the nucleus of the solitary tract and in the hypothalamus, induce the sense of satiety and modulate the energy expenditure [<xref ref-type="bibr" rid="B14">14</xref>]. In addition, GLP-1 seems to be able to upgrade hippocampal neural plasticity improving cognition [<xref ref-type="bibr" rid="B15">15</xref>] and to stimulate receptors located in the amygdala and in the hippocampus, thus exerting anxiolytic and antidepressant effects [<xref ref-type="bibr" rid="B16">16</xref>].</p>
<p>Interestingly, mice assuming a high-fat diet are more likely to present lower levels of short-chain fatty acids (SCFAs) than rodents assuming a low-fat diet [<xref ref-type="bibr" rid="B17">17</xref>]. Moreover, low levels of butyrate have been related with a higher risk to develop type 2 diabetes in humans [<xref ref-type="bibr" rid="B18">18</xref>]. SCFAs are involved in neurotransmission, since they modulate the synthesis of several neurotransmitters regulating behaviour and cognition. In particular, both butyric and propionic acid enhance the expression of tyrosine and tryptophan hydroxylase, enzymes involved in the synthesis of dopamine, noradrenaline, and serotonin [<xref ref-type="bibr" rid="B19">19</xref>]. Interestingly, evidence suggests that several bacteria could directly produce neurotransmitters, including gamma-aminobutyric acid (GABA) and serotonin. Animal studies demonstrate that Lactobacillus rhamnosus is able to modulate GABA receptor expression in the brain, thus exerting a beneficial role in the treatment of mood disorders [<xref ref-type="bibr" rid="B20">20</xref>]. Concerning serotonin, it is mainly produced by the gut enterochromaffin cells and modulates several physiological processes (i.e., mood regulation, sleep, and sexual behaviour). Literature data suggest that Escherichia and Enterococcus are able to produce serotonin both directly and through the production of SCFAs [<xref ref-type="bibr" rid="B21">21</xref>].</p>
<p>In summary, gut microbiota and brain are strictly intertwined and communicate through different ways, including the production of bacteria metabolites, cytokines, and neurotransmitters [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>]. On this ground, it is not surprising that it has been hypothesized that the gut microbiota could play a pivotal role in the pathogenesis of chronic disorders such as depression, AD, and diabetes.</p>
</sec>
<sec id="sec1.3">
<title>1.3. Microbiota, Inflammation, and Oxidative Stress</title>
<p>Among the various functions of gut microbiota, the regulation of oxidative stress (OS) is probably the most fascinating one [<xref ref-type="bibr" rid="B22">22</xref>]. The gastrointestinal tract is rich of sources of nitric oxide (NO), such as intestinal tissues (i.e., mast cells, smooth muscle, and neural plexus), leukocytes, and commensal anaerobes. It has been demonstrated that a high nitrate intake increases both nitrite concentration and NO. In fact, gut lactobacilli and bifidobacteria are able to convert nitrate and nitrite in NO while enhancing the release of NO by host epithelial cells [<xref ref-type="bibr" rid="B23">23</xref>]. In addition to NO production from nitrate, gut streptomycetes and bacilli produce NO through their NO synthetase (NOS) from L-arginine [<xref ref-type="bibr" rid="B23">23</xref>]. NO is the principal neurotransmitter of the nonadrenergic, noncholinergic enteric nervous system and is released by the activation of NMDA receptors by glutamate. While nanomolar concentrations of NO exert a neuroprotective function being involved in signaling and apoptosis, excessive NO production is noxious, being associated with neuroinflammation, cellular damage, axonal degeneration, and neurodegenerative disorders [<xref ref-type="bibr" rid="B10">10</xref>]. An aberrant production of NO leads to detrimental effects due to the generation of reactive oxygen species (ROS), such as superoxide anions (which form the highly reactive peroxynitrite ion, responsible for protein nitrotyrosilation and inhibition of mitochondrial functions) and hydrogen peroxide, which forms the highly reactive hydroxyl radical that is responsible for lipid peroxidation and DNA damage [<xref ref-type="bibr" rid="B24">24</xref>]. The main site of the production of ROS and reactive oxygen nitrogen species (RONS) is represented by the mitochondria, primary energy centre involved in the oxidative reactions leading to adenosine triphosphate (ATP) generation. Recent studies have underlined the existence of an intertalk between host and microbiota mediated by mitochondria [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. Gut microbiota metabolites, SCFAs in particular, influence mitochondrial function reducing ROS production [<xref ref-type="bibr" rid="B27">27</xref>]. Other studies have reported that SCFAs are also associated with a reduction of telomere shortening and DNA damage by altering chromatin structures and inducing the production of the antioxidant glutathione [<xref ref-type="bibr" rid="B28">28</xref>] and increasing COX-2 activity [<xref ref-type="bibr" rid="B29">29</xref>].</p>
<p>If on the one hand, commensal bacteria exert beneficial effects against OS, on the other hand, pathogens (i.e., Salmonella and E. coli) are able to degrade sulphur amino acids leading to hydrogen sulfide (H<sub>2</sub>S) production in the gut. High levels of H<sub>2</sub>S are responsible of several negative effects in the host, such as the inhibition of COX activity and the shifting of the metabolism towards glycolysis, thus leading to an increased lactate and decreased ATP production [<xref ref-type="bibr" rid="B30">30</xref>]. Moreover, it has been demonstrated that the exposure to high levels of H<sub>2</sub>S leads to a decreased mitochondrial oxygen consumption and an overexpression of proinflammatory mediator genes, IL-6 in particular [<xref ref-type="bibr" rid="B31">31</xref>].</p>
<p>Considering the important role of the functionally microbiota-derived active substance on host immunological and inflammatory functions, it is apparent that the maintenance of a “healthy microbiota” becomes fundamental for the individual's wellbeing. See <xref ref-type="fig" rid="fig1">Figure 1</xref> for a visual presentation of how dysbiosis favors OS.</p>
</sec>
</sec>
<sec id="sec2">
<title>2. Alzheimer's Disease</title>
<p>Epidemiological studies reported that 50 million people are affected by dementia worldwide [<xref ref-type="bibr" rid="B32">32</xref>] with an age-specific incidence ranging from 5 per 1000 at the age 65-70 to 80 per 1000 for individuals older than 85 years [<xref ref-type="bibr" rid="B33">33</xref>].</p>
<p>AD is the most frequent neurodegenerative disorders and form of dementia in the elderly [<xref ref-type="bibr" rid="B34">34</xref>].</p>
<p>During the early stages of the “typical” form of AD, the main symptom is represented by episodic memory impairment then accompanied by other cognitive domain deficits (visuospatial, attention, language, and executive functions) leading to a loss of abilities of daily living and dementia [<xref ref-type="bibr" rid="B35">35</xref>].</p>
<p>To date, thanks to biomarker research, AD is considered a slowly chronic progressive brain disease that can be diagnosed several years before the clinic onset, during a “preclinical stage” [<xref ref-type="bibr" rid="B36">36</xref>]. In fact, the pathological hallmarks of AD, including hippocampus atrophy, extracellular amyloid-<italic>β</italic> (A<italic>β</italic>) plaques, and intracellular neurofibrillary tangles of hyperphosphorylated tau protein can be identified up to decades before the occurrence of cognitive decline and behavioural disturbances [<xref ref-type="bibr" rid="B37">37</xref>].</p>
<p>Despite some conflicting results, the role of several genetic [<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>] and modifiable environmental risk factors in the pathogenesis of AD has been documented [<xref ref-type="bibr" rid="B40">40</xref>]. Among the modifiable risk factors, special attention has been given to the role of gut microbiome alteration in the maintenance of the chronic age-related low inflammation [<xref ref-type="bibr" rid="B41">41</xref>].</p>
<sec id="sec2.1">
<title>2.1. Oxidative Stress and Alzheimer's Disease: The Role of Gut Microbiome</title>
<p>From a pathophysiological point of view, as mentioned before, the AD brain is characterized by A<italic>β</italic>1-42 aggregation and neurofibrillary tangles with a consequent immune response activation driven by activated microglia. This immune response activation initially allows A<italic>β</italic> clearance, but, during aging, it undergoes alterations thus leading to a progressive deposition of A<italic>β</italic> plaques which inexorably determines synaptic dysfunction, neuron death, neuroinflammation, and OS [<xref ref-type="bibr" rid="B42">42</xref>].</p>
<p>In particular, in the AD brain, several sources of ROS production have been demonstrated: (1) mitochondrial dysfunction determined by a cytochrome c oxidase deficiency [<xref ref-type="bibr" rid="B43">43</xref>] as well as by an alteration of their permeability due to the OS-related hyperactivation of glycogen synthase kinase (GSK-3) [<xref ref-type="bibr" rid="B44">44</xref>], (2) endoplasmic reticulum dysfunction due to its engagement in the elimination of abundant misfolded proteins, such as hyperphosphorylated tau protein [<xref ref-type="bibr" rid="B45">45</xref>], (3) metal ions (i.e., copper, iron, and zinc) accumulated in the neuritic plaques [<xref ref-type="bibr" rid="B46">46</xref>], and (4) age-related microglial cell hyperactivation with a subsequent high expression and activation of NADPH oxidase resulting in overproduction of hydrogen peroxide [<xref ref-type="bibr" rid="B47">47</xref>].</p>
<p>It should be also emphasized that the CNS is particularly vulnerable to OS for several reasons, including its high oxygen consumption, its use of different reactive species in the signalling process, and its scarce antioxidant metabolism [<xref ref-type="bibr" rid="B48">48</xref>].</p>
<p>Although it is still debated whether OS represents the determinant or the immediate consequence of the neurodegenerative processes, OS is indubitably involved in the key events driving the progressive neuronal loss [<xref ref-type="bibr" rid="B10">10</xref>]. Markers of lipid peroxidation have been, in fact, detected in biological samples of both AD animal models [<xref ref-type="bibr" rid="B49">49</xref>] and patients [<xref ref-type="bibr" rid="B50">50</xref>] as well as high levels of protein oxidation markers, such as carbonyls [<xref ref-type="bibr" rid="B51">51</xref>]. In this scenario, while a “well-balanced” gut microbiota seems to exert a positive role in the reduction of ROS production via SCFA such as N-butyrate [<xref ref-type="bibr" rid="B27">27</xref>], a dysbiosis may lead to systemic inflammation determining, over the years, microglia activation, BBB damage, and consequent crossing of pathogens and immune cells [<xref ref-type="bibr" rid="B52">52</xref>].</p>
<p>The most recent theories, in fact, consider AD not only as a result of a confined brain inflammation but also as the consequence of peripheral inflammatory reaction [<xref ref-type="bibr" rid="B53">53</xref>]. To support these theories, an association between antimicrobial response and A<italic>β</italic> production has been reported. Indeed, A<italic>β</italic> exerts an antimicrobial peptide role against several pathogens such as bacteria [<xref ref-type="bibr" rid="B54">54</xref>] and viruses [<xref ref-type="bibr" rid="B55">55</xref>]. It could therefore be hypothesized a periodic, growing with aging, A<italic>β</italic> production following new infections or reactivation of latent brain infections. Moreover, it has been demonstrated that some microbes are able to contribute to A<italic>β</italic> accumulation producing, themselves, a microbial amyloid. The latter, being similar to the cerebral one, easily reaches the brain due to the age-related increased permeability of gastrointestinal mucosa and BBB; being recognized by the immune cells, microbial amyloid determines a massive release of inflammatory cytokines thus sustaining chronic inflammation in AD [<xref ref-type="bibr" rid="B41">41</xref>].</p>
<p>Unfortunately, it has been demonstrated that the <italic>age-related reduction of microbiota biodiversity</italic>, with the relative abundance of Proteobacteria and decrease of Bifidobacteria, contributes to the occurrence of dementia not only through the significant reduction of beneficial SCFAs but also through interfering with lipid metabolism. In particular, Bifidobacteria could exert a fundamental hypocholesterolemic role both <italic>directly</italic>, reducing the absorption and production of cholesterol and facilitating its faecal elimination [<xref ref-type="bibr" rid="B56">56</xref>], and <italic>indirectly</italic>, increasing the serum levels of leptin, an antiobesity hormone recently associated with hippocampal long-term potentiation and memory impairment prevention [<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>]. Considering that lipids exert a fundamental role in APP trafficking and processing thus influencing the A<italic>β</italic> oligomer production, the maintenance of microbiota biodiversity appears to be fundamental. Moreover, it should be noted that a dysfunctional lipid metabolism has been found to be associated with anxiety [<xref ref-type="bibr" rid="B59">59</xref>], which has been in turn linked to subcortical amyloidosis in nondemented patients [<xref ref-type="bibr" rid="B60">60</xref>].</p>
<p>A recent double-blind controlled trial demonstrated that treating AD patients with a probiotic formulation containing Lactobacilli and Bifidobacteria normalized the serum triglyceride levels and improved cognitive performances, thus confirming the role of microbiota in the maintenance of a balanced lipid metabolism [<xref ref-type="bibr" rid="B61">61</xref>].</p>
<p>Another mechanism through which microbiota protects against cognitive impairment is represented by the documented ability of Lactobacilli to reduce ammonia concentration in rats [<xref ref-type="bibr" rid="B62">62</xref>].</p>
<p>Ammonia is one of the end-products of protein catabolism, historically implicated in the pathogenesis of AD [<xref ref-type="bibr" rid="B63">63</xref>]. Due to its neurotoxic nature even at low concentrations, an efficient astrocyte-modulated brain ammonia detoxification through the formation of glutamine by glutamine synthetase (GS) is crucial [<xref ref-type="bibr" rid="B64">64</xref>]. With aging, a lower brain GS activity has been demonstrated with the consequent elevation of ammonia concentration. In turn, hyperammonemia causes a progressive mitochondrial dysfunction, thus determining an increase in ROS production and superoxidase levels, while favoring the decrease of cytochrome c oxidase, superoxide dismutase, and glutathione peroxidase [<xref ref-type="bibr" rid="B65">65</xref>].</p>
<p>In conclusion, in an era marked by therapeutic failures despite scientific efforts, deepening the knowledge of the diversified mechanisms through which microbiota could exert a role in counteracting cognitive impairment appears to be of fundamental importance. Further research on the effectiveness of microbiota manipulation as a therapeutic tool is needed.</p>
</sec>
</sec>
<sec id="sec3">
<title>3. Depression</title>
<p>Depression is probably the most common mental disorder, affecting more than 17% of the American general population [<xref ref-type="bibr" rid="B66">66</xref>]. It is characterized by depressed mood, apathy, anhedonia, sleep disturbances, appetite or weight changes, psychomotor retardation [<xref ref-type="bibr" rid="B67">67</xref>] or agitation, cognitive impairment, thoughts of guilt, and recurrent thoughts about death or suicide [<xref ref-type="bibr" rid="B68">68</xref>]. This mental disorder, strongly associated with fatigue, loss of productivity, and increased mortality, represents an economic burden for public health [<xref ref-type="bibr" rid="B69">69</xref>].</p>
<p>Even if the aetiology of depression is still unclear, several neurobiological mechanisms seem to play a role in its occurrence such as (1) the reduction of serotonin, norepinephrine, and dopamine; (2) the alteration of the hypothalamic-pituitary-adrenal (HPA) axis with the consequently elevated plasmatic cortisol level; and (3) the imbalance between proinflammatory and anti-inflammatory mediators [<xref ref-type="bibr" rid="B70">70</xref>]. As discussed below, both animal and human studies have demonstrated a certain role of an “altered” microbiota in this biological scenario.</p>
<sec id="sec3.1">
<title>3.1. Gut Microbiota in Depression: The Role of Oxidative Stress</title>
<p>Several studies have reported an imbalance between elevated levels of proinflammatory cytokines, such as IL-1, IL-6, IL-8, IL-12, tumor necrosis factor-alpha (TNF-<italic>α</italic>), and decreased level of anti-inflammatory cytokines, such as transforming growth factor-beta and IL-10 in patients suffering from depression [<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>]. Moreover, nonspecific inflammatory markers (i.e., acute phase protein, <italic>α</italic>1-antitrypsine, haptoglobin, fibrinogen, and C-reactive protein) have been found to be high in depressed patients [<xref ref-type="bibr" rid="B72">72</xref>].</p>
<p>From a biochemical point of view, as mentioned before, the activation of the inflammatory pathway is characterized by a hyperproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS) with a consequent damage of DNA, proteins, mitochondria, and cell membranes [<xref ref-type="bibr" rid="B73">73</xref>]. The presence of an oxidative and nitrosative stress is supported by the detection in depressed patients of high levels of by-products of lipid peroxidation such as malondialdehyde and 4-hydroxynonenal [<xref ref-type="bibr" rid="B74">74</xref>]. Moreover, if on the one hand, depression is characterized by an increased oxidative and nitrosative stress pathway, on the other hand, endogenous antioxidants such as zinc, glutathione, coenzyme Q10, melatonin, and vitamin E have been found to be decreased. These aforementioned substances, involved in the mitochondrial functioning and in the regulation of cAMP/circadian gene, may lead, if deficient, to neurodegeneration and decreased neurogenesis and neuroplasticity [<xref ref-type="bibr" rid="B75">75</xref>]. Probably, the major expression of an “altered” gut microbiota lays just in these oxidative mechanisms. In fact, while germ-free mice present a reduced antioxidant enzyme activity (i.e., catalase, glutathione peroxidase, and superoxide) [<xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>], an altered microbiota can stimulate the NADPH oxidase [<xref ref-type="bibr" rid="B78">78</xref>] and the NO synthesis [<xref ref-type="bibr" rid="B79">79</xref>], thus inducing OS.</p>
<p>The “depression-associated bacteria” are able to induce depressed mood both directly, producing valeric acid (adenosine A1 receptor inverse agonist) [<xref ref-type="bibr" rid="B80">80</xref>], and indirectly, promoting the production of kynurenine from tryptophan [<xref ref-type="bibr" rid="B81">81</xref>].</p>
<p>Moreover, while in physiological conditions, gut microbiota is separated from the systemic immune system by the epithelial barrier, in pathological conditions, it can reach the mesenteric lymph nodes determining the activation of monocytes and macrophages and the consequent production of inflammatory mediators with antibacterial properties, such as lysozyme [<xref ref-type="bibr" rid="B82">82</xref>].</p>
<p>In normal conditions, the gut epithelial barrier is protected from OS and inflammation by a class of ubiquitously expressed intracellular proteins, the heat shock proteins (HSP). These proteins are chaperones and play a role in the synthesis and folding of other proteins [<xref ref-type="bibr" rid="B83">83</xref>].</p>
<p>Due to their role in the repair and stabilization of proteins, evidence suggests that the synthesis of the HSPs is strongly enhanced in physical and psychological stressful conditions [<xref ref-type="bibr" rid="B84">84</xref>]. Nevertheless, if on the one hand, the upregulation of the HSPs can be considered as a cellular “defence” mechanism, on the other hand, their release in the extracellular matrix, occurring during cellular necrosis or apoptosis, can be remarkably harmful. Extracellular HSPs, in fact, are able to stimulate an inflammatory response leading to an increased proinflammatory cytokine secretion [<xref ref-type="bibr" rid="B84">84</xref>]. The demonstration of high plasmatic concentration of extracellular HSP70 in depressed patients has led to hypothesize that it could play a role in the occurrence of mood disorders [<xref ref-type="bibr" rid="B85">85</xref>]. Interestingly, the physiological epithelial HSP tone is influenced by gut microbiota activity and diversity. Several Bifidobacteria and Lactobacilli are, in fact, strong inducers of gut epithelial HSPs, thus contributing to gut protection [<xref ref-type="bibr" rid="B86">86</xref>].</p>
<p>The relationship between depression and microbiota has been known for several decades, when animal studies reported that stressed mice presented marked reductions of the number of gut lactobacilli [<xref ref-type="bibr" rid="B87">87</xref>]. Recently, human studies have confirmed this early observation, reporting a less represented microbial diversity, with a relative abundance of <italic>Bacteroidetes</italic> and a reduction of <italic>Lachnospiraceae</italic>, in depressed patients [<xref ref-type="bibr" rid="B88">88</xref>]. In addition, chronic depressed subjects present high plasmatic levels of immunoglobulin (Ig) A and IgM antibodies against the LPS of <italic>Enterobacteriaceae</italic>, thus supporting the hypothesis that microbiota could play a role in the occurrence of depression probably sustaining a chronic inflammatory status [<xref ref-type="bibr" rid="B82">82</xref>]. Moreover, stressed germ-free mice present high circulating levels of ACHT and corticosterone, depression-sustaining hormone [<xref ref-type="bibr" rid="B89">89</xref>].</p>
<p>On these grounds, even if literature data still report conflicting results, the interest in treating depression through the administration of probiotics is growing so that the term “psychobiotics” is increasingly used. However, despite probiotics are able to decrease the plasmatic levels of cortisol with a consequent psychological wellbeing and a reduction of depressive symptoms [<xref ref-type="bibr" rid="B90">90</xref>], literature data are still inconsistent. In fact, while some studies demonstrated the efficacy of probiotic augmentation in the reduction of depressive symptoms in drug-resistant patients [<xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B92">92</xref>], the administration of probiotics alone seems to be ineffective [<xref ref-type="bibr" rid="B93">93</xref>].</p>
<p>Nonetheless, it is undeniable that the potential usefulness of probiotics in major depression is a fascinating and worthy of investigation topic, also considering the elevated tolerability of these compounds.</p>
</sec>
</sec>
<sec id="sec4">
<title>4. Type 2 Diabetes Mellitus</title>
<p>Diabetes and obesity, two world epidemics, represent a global challenge for health care [<xref ref-type="bibr" rid="B94">94</xref>].</p>
<p>The 2016 <italic>Global Report on Diabetes</italic> by the World Health Organization (WHO) states that in 2014 the prevalence of diabetes reached up to 8.5% in the adult population, while more than 1 in 10 adults were obese [<xref ref-type="bibr" rid="B95">95</xref>]. Diabetes mellitus was the 7<sup>th</sup> cause of death in 2016 and is projected to move up in the rankings by 2030 [<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B97">97</xref>].</p>
<p>Hence, research pertaining obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM) has been focusing on the identification of potentially modifiable dysfunctions, among which dysbiosis of the gut microbiota has been attracting much interest [<xref ref-type="bibr" rid="B98">98</xref>–<xref ref-type="bibr" rid="B101">101</xref>].</p>
<p>As previously stated in this review, gut microbiota plays a fundamental role in physiological and pathophysiological processes occurring in the host and it is apparent how diet could directly influence the fine balance of the intestinal ecosystem [<xref ref-type="bibr" rid="B102">102</xref>–<xref ref-type="bibr" rid="B105">105</xref>].</p>
<sec id="sec4.1">
<title>4.1. Gut Microbiota in Obesity, Insulin Resistance, and T2DM: The Role of Oxidative Stress</title>
<p>Obese individuals are frequently characterized by insulin resistance, a condition associated with low-grade subclinical inflammation leading to hyperglycemia and favoring the onset of T2DM [<xref ref-type="bibr" rid="B106">106</xref>].</p>
<p>An animal-model study demonstrated how gut microbiome transplant from twin mice discordant for obesity to germ-free mice influenced the metabolic arrangement of the host. More specifically, mice receiving faecal transplant from obese donors had a higher tendency to develop obesity compared to mouse receiving the transplant from a lean donor. Interestingly, diet modulated the colonizing of the microbiome and acted as a protector from developing the obesity phenotype [<xref ref-type="bibr" rid="B107">107</xref>].</p>
<p>Differences between obese and lean people both in terms of concentration and type of resident bacterial population have been reported. Overall, individuals with a low bacterial richness are characterized by marked adiposity, insulin resistance, and dyslipidaemia [<xref ref-type="bibr" rid="B108">108</xref>]. <italic>Firmicutes</italic> and <italic>Bacteroides</italic> phyla account for the 90% of the adult gut flora. An imbalance between the two species has been linked to obesity with conflicting results, but it seems that a reduced production of the microbiota-induced fermentation product butyrate (exerting anti-inflammatory and antioxidative properties and increasing insulin sensitivity in mice) and an increased release of LPS (already described as endotoxin) could favor obesity; the latter is characterized by a microbiota prone to harvest energy from diet [<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B110">110</xref>].</p>
<p>Concerning T2DM, gut alterations lead to an enrichment in membrane transport of sugars, branched-chain amino acid transport and sulfate reduction, decreased butyrate biosynthesis, and OS response that could account for the proinflammatory state characterizing diabetes. Interestingly, patients suffering from T2DM show a dysbiotic condition characterized by a decrease of butyrate-producing bacteria (such as Firmicutes, Roseburia intestinalis, and Faecalibacterium prausnitzii) and an increase in opportunistic pathogens. Despite this unfavorable condition, the gut environment of T2DM attempts to limit OS, with an increase in functions related to OS resistance, such as catalase, peroxiredoxin, and glutathione reductase. In general, despite the role of some metabolites (such as butyrate) needs to be further confirmed, it has been hypothesized that dysbiosis in T2DM could be related to qualitative, more than quantitative, changes in the gastrointestinal ecosystem and a condition of OS that could increase the risk of diabetes complications [<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B111">111</xref>].</p>
<p>While scientific evidence supports the link between gut microbiota and metabolic syndrome [<xref ref-type="bibr" rid="B100">100</xref>], the relationship between inflammation, gut microbiome, and metabolic alterations has not yet been clearly elucidated.</p>
<p>A potential interconnection between these three factors could be represented by diet; indeed, it has been reported that a high-fat diet leads to an increase in the proportion of lipopolysaccharide- (LPS-) containing microbiota and in the LPS plasma levels, thus leading to the so-called endotoxemia. The latter contributes to the occurrence of insulin resistance and accounts for chronic low-grade inflammation and OS characterizing metabolic syndrome. The circulation of endotoxins is made possible through the permeability alterations and the changes in composition affecting the gut [<xref ref-type="bibr" rid="B112">112</xref>, <xref ref-type="bibr" rid="B113">113</xref>]. LPS directly sustain insulin resistance and inflammation via toll-like receptor (TLR) signaling. TLR4 in particular serves as a coreceptor for the monocyte differentiation antigen CD14 and mediates the LPS-induced inflammatory cascade and innate immune response [<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>].</p>
<p>The discussed findings have practical implications. In fact, it can be inferred that the manipulation of intestinal ecosystem could interfere with the dysbiosis-related prooxidative and proinflammatory mechanisms described above. Preliminary reports support this hypothesis. In fact, the use of antibiotics in mice has been related to reduced endotoxemia, OS, and inflammation [<xref ref-type="bibr" rid="B115">115</xref>]. In addition, <italic>Lactobacillus</italic>, <italic>Bifidobacterium</italic>, and <italic>Enterobacter halii</italic> are bacterial candidates for the treatment of obesity, even though more studies are needed to confirm their efficacy [<xref ref-type="bibr" rid="B116">116</xref>]. In terms of future perspectives, the characterization of faecal metagenome could help identifying people at high risk of developing metabolic and inflammatory complications [<xref ref-type="bibr" rid="B18">18</xref>].</p>
</sec>
</sec>
<sec id="sec5">
<title>5. Gut-Brain Axis: Therapeutic Perspectives</title>
<p>As stated above in the sections dedicated to AD, depression, and diabetes, several studies have reported the usefulness of microbiota manipulation in the treatment of these disorders [<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B115">115</xref>]. In recent years, special attention has been given by researchers to probiotic supplementation with promising results [<xref ref-type="bibr" rid="B117">117</xref>–<xref ref-type="bibr" rid="B119">119</xref>]. Despite further insights on the efficacy of dysbiosis restoration in these disorders are needed, the gut-brain axis cannot be simply dismissed as a “fashionable topic” [<xref ref-type="bibr" rid="B120">120</xref>].</p>
</sec>
<sec id="sec6">
<title>6. Conclusion</title>
<p>Dysbiosis has been demonstrated to exert regulatory functions on inflammation and OS and represents a pathogenetic contributor shared by AD, depression, and T2DM [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B101">101</xref>], three disorders characterized by a prooxidative and proinflammatory condition [<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B111">111</xref>]. The gut-brain axis can account for the molecular similarities linking these disorders, also confirmed by the high rates of comorbidity between depression and T2DM, which in turn increase the risk of dementia. Metabolism, cognition, and mood are strictly intertwined; if glucose toxicity can directly interfere with the cognitive functions, the insulin pathway is involved in amyloid formation, while depression can precipitate neuronal damage through inflammatory mechanisms [<xref ref-type="bibr" rid="B121">121</xref>]. Deepening the knowledge on the pathogenetic mechanisms of these burdening disorders could open new scenarios. In fact, the manipulation of the gut environment could be further investigated as a preventive and/or therapeutic tool with (potentially) a good safety profile.</p>
</sec>
</body>
<back>
<sec>
<title>Conflicts of Interest</title>
<p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p>
</sec>
<sec>
<title>Authors' Contributions</title>
<p>Maria Luca and Maurizio Di Mauro contributed equally to this work.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bermon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Petriz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kajeniene</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prestes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Castell</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>O. L.</given-names>
</name>
</person-group>
<article-title>The microbiota: an exercise immunology perspective</article-title>
<source/>
<italic toggle="yes">Exercise Immunology Review</italic>
<year>2015</year>
<volume>21</volume>
<fpage>70</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">25825908</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MetaHIT Consortium</surname>
</name>
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2010</year>
<volume>464</volume>
<issue>7285</issue>
<fpage>59</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1038/nature08821</pub-id>
<pub-id pub-id-type="other">2-s2.0-77950251400</pub-id>
<pub-id pub-id-type="pmid">20203603</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Lauber</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fierer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bacterial community variation in human body habitats across space and time</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2009</year>
<volume>326</volume>
<issue>5960</issue>
<fpage>1694</fpage>
<lpage>1697</lpage>
<pub-id pub-id-type="doi">10.1126/science.1177486</pub-id>
<pub-id pub-id-type="other">2-s2.0-72949091232</pub-id>
<pub-id pub-id-type="pmid">19892944</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kinross</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Host-gut microbiota metabolic interactions</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2012</year>
<volume>336</volume>
<issue>6086</issue>
<fpage>1262</fpage>
<lpage>1267</lpage>
<pub-id pub-id-type="doi">10.1126/science.1223813</pub-id>
<pub-id pub-id-type="other">2-s2.0-84861978076</pub-id>
<pub-id pub-id-type="pmid">22674330</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherwin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J. F.</given-names>
</name>
</person-group>
<article-title>Recent developments in understanding the role of the gut microbiota in brain health and disease</article-title>
<source/>
<italic toggle="yes">Annals of the New York Academy of Sciences</italic>
<year>2018</year>
<volume>1420</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.13416</pub-id>
<pub-id pub-id-type="other">2-s2.0-85048193971</pub-id>
<pub-id pub-id-type="pmid">28768369</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quigley</surname>
<given-names>E. M. M.</given-names>
</name>
</person-group>
<article-title>Microbiota-brain-gut axis and neurodegenerative diseases</article-title>
<source/>
<italic toggle="yes">Current Neurology and Neuroscience Reports</italic>
<year>2017</year>
<volume>17</volume>
<issue>12</issue>
<fpage>p. 94</fpage>
<pub-id pub-id-type="doi">10.1007/s11910-017-0802-6</pub-id>
<pub-id pub-id-type="other">2-s2.0-85032031823</pub-id>
<pub-id pub-id-type="pmid">29039142</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Moriss</surname>
<given-names>M. M.</given-names>
</name>
</person-group>
<article-title>Vagus nerve</article-title>
<source/>
<italic toggle="yes">Encyclopedia of Science</italic>
<year>2013</year>
<publisher-name>Salem Press</publisher-name>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hyland</surname>
<given-names>N. P.</given-names>
</name>
</person-group>
<article-title>Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders</article-title>
<source/>
<italic toggle="yes">Frontiers in Cellular Neuroscience</italic>
<year>2015</year>
<volume>9</volume>
<fpage>p. 392</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00392</pub-id>
<pub-id pub-id-type="other">2-s2.0-84944446673</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>The impact of microbiota-gut-brain axis on diabetic cognition impairment</article-title>
<source/>
<italic toggle="yes">Frontiers in Aging Neuroscience</italic>
<year>2017</year>
<volume>27</volume>
<issue>9</issue>
<fpage>p. 106</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00106</pub-id>
<pub-id pub-id-type="other">2-s2.0-85018384298</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The role of oxidative damage in the pathogenesis and progression of Alzheimer’s disease and vascular dementia</article-title>
<source/>
<italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic>
<year>2015</year>
<volume>2015</volume>
<fpage>8</fpage>
<pub-id pub-id-type="publisher-id">504678</pub-id>
<pub-id pub-id-type="doi">10.1155/2015/504678</pub-id>
<pub-id pub-id-type="other">2-s2.0-84939489517</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes in pro-inflammatory cytokine levels and late-life depression: a two year population based longitudinal study</article-title>
<source/>
<italic toggle="yes">Psychoneuroendocrinology</italic>
<year>2018</year>
<volume>90</volume>
<fpage>85</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2018.02.006</pub-id>
<pub-id pub-id-type="other">2-s2.0-85042236065</pub-id>
<pub-id pub-id-type="pmid">29471232</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Latorre</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sternini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De Giorgio</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Greenwood-Van Meerveld</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Enteroendocrine cells: a review of their role in brain–gut communication</article-title>
<source/>
<italic toggle="yes">Neurogastroenterology and Motility</italic>
<year>2016</year>
<volume>28</volume>
<issue>5</issue>
<fpage>620</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1111/nmo.12754</pub-id>
<pub-id pub-id-type="other">2-s2.0-84952333567</pub-id>
<pub-id pub-id-type="pmid">26691223</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity</article-title>
<source/>
<italic toggle="yes">The FASEB Journal</italic>
<year>2015</year>
<volume>29</volume>
<issue>6</issue>
<fpage>2397</fpage>
<lpage>2411</lpage>
<pub-id pub-id-type="doi">10.1096/fj.14-265983</pub-id>
<pub-id pub-id-type="other">2-s2.0-84933505154</pub-id>
<pub-id pub-id-type="pmid">25713030</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>P. V.</given-names>
</name>
<name>
<surname>Hamr</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Duca</surname>
<given-names>F. A.</given-names>
</name>
</person-group>
<article-title>Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota</article-title>
<source/>
<italic toggle="yes">Cellular and Molecular Life Sciences</italic>
<year>2016</year>
<volume>73</volume>
<issue>4</issue>
<fpage>737</fpage>
<lpage>755</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-015-2083-z</pub-id>
<pub-id pub-id-type="other">2-s2.0-84957427864</pub-id>
<pub-id pub-id-type="pmid">26542800</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z. F.</given-names>
</name>
<name>
<surname>Holscher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y. Z.</given-names>
</name>
</person-group>
<article-title>Val<sup>8</sup> glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains</article-title>
<source/>
<italic toggle="yes">European Journal of Pharmacology</italic>
<year>2012</year>
<volume>674</volume>
<issue>2-3</issue>
<fpage>280</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2011.11.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-84855548096</pub-id>
<pub-id pub-id-type="pmid">22115895</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderberg</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Hansson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nissbrandt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bergquist</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Skibicka</surname>
<given-names>K. P.</given-names>
</name>
</person-group>
<article-title>GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality</article-title>
<source/>
<italic toggle="yes">Psychoneuroendocrinology</italic>
<year>2016</year>
<volume>65</volume>
<fpage>54</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.11.021</pub-id>
<pub-id pub-id-type="other">2-s2.0-84958175636</pub-id>
<pub-id pub-id-type="pmid">26724568</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berger</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Falck</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Linninge</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cereal byproducts have prebiotic potential in mice fed a high-fat diet</article-title>
<source/>
<italic toggle="yes">Journal of Agricultural and Food Chemistry</italic>
<year>2014</year>
<volume>62</volume>
<issue>32</issue>
<fpage>8169</fpage>
<lpage>8178</lpage>
<pub-id pub-id-type="doi">10.1021/jf502343v</pub-id>
<pub-id pub-id-type="other">2-s2.0-84906225091</pub-id>
<pub-id pub-id-type="pmid">25041844</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Tremaroli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nookaew</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut metagenome in European women with normal, impaired and diabetic glucose control</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2013</year>
<volume>498</volume>
<issue>7452</issue>
<fpage>99</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1038/nature12198</pub-id>
<pub-id pub-id-type="other">2-s2.0-84878709716</pub-id>
<pub-id pub-id-type="pmid">23719380</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nankova</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>MacFabe</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>La Gamma</surname>
<given-names>E. F.</given-names>
</name>
</person-group>
<article-title>Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells—possible relevance to autism spectrum disorders</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2014</year>
<volume>9</volume>
<issue>8, article e103740</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0103740</pub-id>
<pub-id pub-id-type="other">2-s2.0-84908185298</pub-id>
<pub-id pub-id-type="pmid">25170769</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bravo</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Forsythe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>M. V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2011</year>
<volume>108</volume>
<issue>38</issue>
<fpage>16050</fpage>
<lpage>16055</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1102999108</pub-id>
<pub-id pub-id-type="other">2-s2.0-80052965474</pub-id>
<pub-id pub-id-type="pmid">21876150</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cryan</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T. G.</given-names>
</name>
</person-group>
<article-title>Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour</article-title>
<source/>
<italic toggle="yes">Nature Reviews. Neuroscience</italic>
<year>2012</year>
<volume>13</volume>
<issue>10</issue>
<fpage>701</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3346</pub-id>
<pub-id pub-id-type="other">2-s2.0-84866546211</pub-id>
<pub-id pub-id-type="pmid">22968153</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of an antioxidant blend on intestinal redox status and major microbiota in early weaned piglets</article-title>
<source/>
<italic toggle="yes">Nutrition</italic>
<year>2014</year>
<volume>30</volume>
<issue>5</issue>
<fpage>584</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2013.10.018</pub-id>
<pub-id pub-id-type="other">2-s2.0-84897067458</pub-id>
<pub-id pub-id-type="pmid">24698350</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oleskin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Shenderov</surname>
<given-names>B. A.</given-names>
</name>
</person-group>
<article-title>Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota</article-title>
<source/>
<italic toggle="yes">Microbial Ecology in Health and Disease</italic>
<year>2016</year>
<volume>27, article 30971</volume>
<pub-id pub-id-type="doi">10.3402/mehd.v27.30971</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tse</surname>
<given-names>J. K. Y.</given-names>
</name>
</person-group>
<article-title>Gut microbiota, nitric oxide, and microglia as prerequisites for neurodegenerative disorders</article-title>
<source/>
<italic toggle="yes">ACS Chemical Neuroscience</italic>
<year>2017</year>
<volume>8</volume>
<issue>7</issue>
<fpage>1438</fpage>
<lpage>1447</lpage>
<pub-id pub-id-type="doi">10.1021/acschemneuro.7b00176</pub-id>
<pub-id pub-id-type="other">2-s2.0-85024915878</pub-id>
<pub-id pub-id-type="pmid">28640632</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saint-Georges-Chaumet</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Edeas</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Microbiota-mitochondria inter-talk: consequence for microbiota-host interaction</article-title>
<source/>
<italic toggle="yes">Pathogens and Disease</italic>
<year>2015</year>
<volume>74</volume>
<issue>1, article ftv096</issue>
<pub-id pub-id-type="doi">10.1093/femspd/ftv096</pub-id>
<pub-id pub-id-type="other">2-s2.0-84989171980</pub-id>
<pub-id pub-id-type="pmid">26500226</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Letesson</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Arnould</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Mitochondria: a target for bacteria</article-title>
<source/>
<italic toggle="yes">Biochemical Pharmacology</italic>
<year>2015</year>
<volume>94</volume>
<issue>3</issue>
<fpage>173</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2015.02.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-84925487212</pub-id>
<pub-id pub-id-type="pmid">25707982</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mottawea</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Mühlbauer</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn’s disease</article-title>
<source/>
<italic toggle="yes">Nature Communications</italic>
<year>2016</year>
<volume>7</volume>
<issue>1, article 13419</issue>
<pub-id pub-id-type="doi">10.1038/ncomms13419</pub-id>
<pub-id pub-id-type="other">2-s2.0-84996569936</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamer</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Jonkers</surname>
<given-names>D. M. A. E.</given-names>
</name>
<name>
<surname>Bast</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Butyrate modulates oxidative stress in the colonic mucosa of healthy humans</article-title>
<source/>
<italic toggle="yes">Clinical Nutrition</italic>
<year>2009</year>
<volume>28</volume>
<issue>1</issue>
<fpage>88</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.clnu.2008.11.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-59149103242</pub-id>
<pub-id pub-id-type="pmid">19108937</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valladares</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sankar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2010</year>
<volume>5</volume>
<issue>5, article e10507</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010507</pub-id>
<pub-id pub-id-type="other">2-s2.0-77956409750</pub-id>
<pub-id pub-id-type="pmid">20463897</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leschelle</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Goubern</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Andriamihaja</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide</article-title>
<source/>
<italic toggle="yes">Biochimica et Biophysica Acta (BBA) - General Subjects</italic>
<year>2005</year>
<volume>1725</volume>
<issue>2</issue>
<fpage>201</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2005.06.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-24344485617</pub-id>
<pub-id pub-id-type="pmid">15996823</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaumont</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Andriamihaja</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: the adaptive response</article-title>
<source/>
<italic toggle="yes">Free Radical Biology &amp; Medicine</italic>
<year>2016</year>
<volume>93</volume>
<fpage>155</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.01.028</pub-id>
<pub-id pub-id-type="other">2-s2.0-84957868326</pub-id>
<pub-id pub-id-type="pmid">26849947</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="book">
<collab>Alzheimer’s Disease International</collab>
<source/>
<italic toggle="yes">World Alzheimer Report, 2018: The State of the Art of Dementia Research: New Frontiers</italic>
<year>2018</year>
<publisher-loc>London</publisher-loc>
<publisher-name>Alzheimer’s Disease International (ADI)</publisher-name>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sosa-Ortiz</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Acosta-Castillo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Prince</surname>
<given-names>M. J.</given-names>
</name>
</person-group>
<article-title>Epidemiology of dementias and Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Archives of Medical Research</italic>
<year>2012</year>
<volume>43</volume>
<issue>8</issue>
<fpage>600</fpage>
<lpage>608</lpage>
<pub-id pub-id-type="doi">10.1016/j.arcmed.2012.11.003</pub-id>
<pub-id pub-id-type="other">2-s2.0-84871657931</pub-id>
<pub-id pub-id-type="pmid">23159715</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>dos Santos Picanco</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Ozela</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>de Fatima de Brito Brito</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alzheimer’s disease: a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment</article-title>
<source/>
<italic toggle="yes">Current Medicinal Chemistry</italic>
<year>2018</year>
<volume>25</volume>
<issue>26</issue>
<fpage>3141</fpage>
<lpage>3159</lpage>
<pub-id pub-id-type="doi">10.2174/0929867323666161213101126</pub-id>
<pub-id pub-id-type="other">2-s2.0-85053112872</pub-id>
<pub-id pub-id-type="pmid">30191777</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKhann</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Knopman</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Chertkow</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Alzheimers Dement</italic>
<year>2011</year>
<volume>7</volume>
<issue>3</issue>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-79956142378</pub-id>
<pub-id pub-id-type="pmid">21514250</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubois</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hampel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>H. H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria</article-title>
<source/>
<italic toggle="yes">Alzheimers Dement</italic>
<year>2016</year>
<volume>12</volume>
<issue>3</issue>
<fpage>292</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2016.02.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-84962325429</pub-id>
<pub-id pub-id-type="pmid">27012484</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blennow</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>de Leon</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Zetterberg</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Lancet</italic>
<year>2006</year>
<volume>368</volume>
<issue>9533</issue>
<fpage>387</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(06)69113-7</pub-id>
<pub-id pub-id-type="other">2-s2.0-33746310315</pub-id>
<pub-id pub-id-type="pmid">16876668</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruno</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Quattrocchi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nicoletti</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease</article-title>
<source/>
<italic toggle="yes">Neuroscience Letters</italic>
<year>2010</year>
<volume>482</volume>
<issue>2</issue>
<fpage>112</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2010.07.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-77955773912</pub-id>
<pub-id pub-id-type="pmid">20637261</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veitch</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Aisen</surname>
<given-names>P. S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Understanding disease progression and improving Alzheimer’s disease clinical trials: recent highlights from the Alzheimer’s Disease Neuroimaging Initiative</article-title>
<source/>
<italic toggle="yes">Alzheimers Dement</italic>
<year>2019</year>
<volume>15</volume>
<issue>1</issue>
<fpage>106</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2018.08.005</pub-id>
<pub-id pub-id-type="pmid">30321505</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk factors of transition from mild cognitive impairment to Alzheimer’s disease and death: a cohort study</article-title>
<source/>
<italic toggle="yes">Comprehensive Psychiatry</italic>
<year>2017</year>
<volume>78</volume>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1016/j.comppsych.2017.07.003</pub-id>
<pub-id pub-id-type="other">2-s2.0-85029333288</pub-id>
<pub-id pub-id-type="pmid">28806610</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lukiw</surname>
<given-names>W. J.</given-names>
</name>
</person-group>
<article-title>Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Journal of Nature and Science</italic>
<year>2015</year>
<volume>1</volume>
<issue>7, article e138</issue>
<pub-id pub-id-type="pmid">26097896</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penke</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bogár</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fülöp</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>
<italic>β</italic>-Amyloid and the pathomechanisms of Alzheimer’s disease: a comprehensive view</article-title>
<source/>
<italic toggle="yes">Molecules</italic>
<year>2017</year>
<volume>22</volume>
<issue>10, article E1692</issue>
<pub-id pub-id-type="doi">10.3390/molecules22101692</pub-id>
<pub-id pub-id-type="other">2-s2.0-85032886167</pub-id>
<pub-id pub-id-type="pmid">28994715</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castellani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Aliev</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of mitochondrial dysfunction in Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Journal of Neuroscience Research</italic>
<year>2002</year>
<volume>70</volume>
<issue>3</issue>
<fpage>357</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.10389</pub-id>
<pub-id pub-id-type="other">2-s2.0-0037010312</pub-id>
<pub-id pub-id-type="pmid">12391597</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy</article-title>
<source/>
<italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic>
<year>2016</year>
<volume>2016</volume>
<fpage>12</fpage>
<pub-id pub-id-type="publisher-id">3030547</pub-id>
<pub-id pub-id-type="doi">10.1155/2016/3030547</pub-id>
<pub-id pub-id-type="other">2-s2.0-84984797910</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhandary</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Marahatta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>H. J.</given-names>
</name>
</person-group>
<article-title>An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases</article-title>
<source/>
<italic toggle="yes">International Journal of Molecular Sciences</italic>
<year>2013</year>
<volume>14</volume>
<issue>1</issue>
<fpage>434</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.3390/ijms14010434</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872192695</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adlard</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Bush</surname>
<given-names>A. I.</given-names>
</name>
</person-group>
<article-title>Metals and Alzheimer’s disease: how far have we come in the clinic?</article-title>
<source/>
<italic toggle="yes">Journal of Alzheimer's Disease</italic>
<year>2018</year>
<volume>62</volume>
<issue>3</issue>
<fpage>1369</fpage>
<lpage>1379</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-170662</pub-id>
<pub-id pub-id-type="other">2-s2.0-85044406622</pub-id>
<pub-id pub-id-type="pmid">29562528</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Molecular bases of Alzheimer’s disease and neurodegeneration: the role of neuroglia</article-title>
<source/>
<italic toggle="yes">Aging and Disease</italic>
<year>2018</year>
<volume>9</volume>
<issue>6</issue>
<fpage>1134</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="doi">10.14336/AD.2018.0201</pub-id>
<pub-id pub-id-type="pmid">30574424</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cobley</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Fiorello</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>D. M.</given-names>
</name>
</person-group>
<article-title>13 reasons why the brain is susceptible to oxidative stress</article-title>
<source/>
<italic toggle="yes">Redox Biology</italic>
<year>2018</year>
<volume>15</volume>
<fpage>490</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1016/j.redox.2018.01.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-85041584254</pub-id>
<pub-id pub-id-type="pmid">29413961</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raefsky</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Furman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Milne</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid <italic>β</italic>-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Neurobiology of Aging</italic>
<year>2018</year>
<volume>66</volume>
<fpage>165</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.02.024</pub-id>
<pub-id pub-id-type="other">2-s2.0-85044726298</pub-id>
<pub-id pub-id-type="pmid">29579687</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peña-Bautista</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vigor</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Galano</surname>
<given-names>J. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer disease detection</article-title>
<source/>
<italic toggle="yes">Free Radical Biology &amp; Medicine</italic>
<year>2018</year>
<volume>124</volume>
<fpage>388</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.06.038</pub-id>
<pub-id pub-id-type="other">2-s2.0-85049327286</pub-id>
<pub-id pub-id-type="pmid">29969716</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Redox proteomic profiling of specifically carbonylated proteins in the serum of triple transgenic Alzheimer’s disease mice</article-title>
<source/>
<italic toggle="yes">International Journal of Molecular Sciences</italic>
<year>2016</year>
<volume>17</volume>
<issue>4</issue>
<fpage>p. 469</fpage>
<pub-id pub-id-type="doi">10.3390/ijms17040469</pub-id>
<pub-id pub-id-type="other">2-s2.0-84963768551</pub-id>
<pub-id pub-id-type="pmid">27077851</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sochocka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diniz</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Leszek</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Inflammatory response in the CNS: friend or foe?</article-title>
<source/>
<italic toggle="yes">Molecular Neurobiology</italic>
<year>2017</year>
<volume>54</volume>
<issue>10</issue>
<fpage>8071</fpage>
<lpage>8089</lpage>
<pub-id pub-id-type="doi">10.1007/s12035-016-0297-1</pub-id>
<pub-id pub-id-type="other">2-s2.0-84997496789</pub-id>
<pub-id pub-id-type="pmid">27889895</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>le Page</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>E. H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role of the peripheral innate immune system in the development of Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Experimental Gerontology</italic>
<year>2018</year>
<volume>107</volume>
<fpage>59</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1016/j.exger.2017.12.019</pub-id>
<pub-id pub-id-type="other">2-s2.0-85039758906</pub-id>
<pub-id pub-id-type="pmid">29275160</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Little</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>MacIntyre</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Balin</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Appelt</surname>
<given-names>D. M.</given-names>
</name>
</person-group>
<article-title>Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice</article-title>
<source/>
<italic toggle="yes">Neurobiology of Aging</italic>
<year>2004</year>
<volume>25</volume>
<issue>4</issue>
<fpage>419</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-4580(03)00127-1</pub-id>
<pub-id pub-id-type="other">2-s2.0-1542298233</pub-id>
<pub-id pub-id-type="pmid">15013562</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Aguila</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Araya</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation</article-title>
<source/>
<italic toggle="yes">Journal of Alzheimer's Disease</italic>
<year>2014</year>
<volume>39</volume>
<issue>4</issue>
<fpage>849</fpage>
<lpage>859</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-131706</pub-id>
<pub-id pub-id-type="other">2-s2.0-84896862674</pub-id>
<pub-id pub-id-type="pmid">24296813</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Q. F.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>F. G.</given-names>
</name>
</person-group>
<article-title>Effects of four <italic>Bifidobacteria</italic> on obesity in high-fat diet induced rats</article-title>
<source/>
<italic toggle="yes">World Journal of Gastroenterology</italic>
<year>2010</year>
<volume>16</volume>
<issue>27</issue>
<fpage>3394</fpage>
<lpage>3401</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v16.i27.3394</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954838946</pub-id>
<pub-id pub-id-type="pmid">20632441</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eslami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sadeghi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Goshadrou</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Chronic ghrelin administration restores hippocampal long-term potentiation and ameliorates memory impairment in rat model of Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Hippocampus</italic>
<year>2018</year>
<volume>28</volume>
<issue>10</issue>
<fpage>724</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.23002</pub-id>
<pub-id pub-id-type="other">2-s2.0-85052959583</pub-id>
<pub-id pub-id-type="pmid">30009391</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats</article-title>
<source/>
<italic toggle="yes">Lipids in Health and Disease</italic>
<year>2011</year>
<volume>10</volume>
<issue>1</issue>
<fpage>p. 116</fpage>
<pub-id pub-id-type="doi">10.1186/1476-511X-10-116</pub-id>
<pub-id pub-id-type="other">2-s2.0-79960193263</pub-id>
<pub-id pub-id-type="pmid">21745411</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pistorio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Messina</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Autonomic nervous system and lipid metabolism: findings in anxious-depressive spectrum and eating disorders</article-title>
<source/>
<italic toggle="yes">Lipids in Health and Disease</italic>
<year>2011</year>
<volume>10</volume>
<issue>1</issue>
<fpage>p. 192</fpage>
<pub-id pub-id-type="doi">10.1186/1476-511X-10-192</pub-id>
<pub-id pub-id-type="other">2-s2.0-80054987103</pub-id>
<pub-id pub-id-type="pmid">22034981</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanseeuw</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Jonas</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of anxiety with subcortical amyloidosis in cognitively normal older adults</article-title>
<source/>
<italic toggle="yes">Molecular Psychiatry</italic>
<year>2018</year>
<pub-id pub-id-type="doi">10.1038/s41380-018-0214-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-85052518793</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akbari</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Asemi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Daneshvar Kakhaki</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial</article-title>
<source/>
<italic toggle="yes">Frontiers in Aging Neuroscience</italic>
<year>2016</year>
<volume>8</volume>
<fpage>p. 256</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2016.00256</pub-id>
<pub-id pub-id-type="other">2-s2.0-85006265680</pub-id>
<pub-id pub-id-type="pmid">27891089</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat</article-title>
<source/>
<italic toggle="yes">Science China. Life Sciences</italic>
<year>2014</year>
<volume>57</volume>
<issue>3</issue>
<fpage>327</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1007/s11427-014-4615-4</pub-id>
<pub-id pub-id-type="other">2-s2.0-84895928519</pub-id>
<pub-id pub-id-type="pmid">24554471</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blume</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Hyperammonemia and Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Journal of the American Geriatrics Society</italic>
<year>1989</year>
<volume>37</volume>
<issue>11</issue>
<fpage>p. 1102</fpage>
<pub-id pub-id-type="doi">10.1111/j.1532-5415.1989.tb06935.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-0024760344</pub-id>
<pub-id pub-id-type="pmid">2809062</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.-T.</given-names>
</name>
</person-group>
<article-title>Blood ammonia as a possible etiological agent for Alzheimer’s disease</article-title>
<source/>
<italic toggle="yes">Nutrients</italic>
<year>2018</year>
<volume>10</volume>
<issue>5, article E564</issue>
<pub-id pub-id-type="doi">10.3390/nu10050564</pub-id>
<pub-id pub-id-type="other">2-s2.0-85046619396</pub-id>
<pub-id pub-id-type="pmid">29734664</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosenko</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Solomadin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tikhonova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Aliev</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kaminsky</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-<italic>β</italic> peptides, systemic ammonia and erythrocyte energy metabolism</article-title>
<source/>
<italic toggle="yes">CNS &amp; Neurological Disorders Drug Targets</italic>
<year>2014</year>
<volume>13</volume>
<issue>1</issue>
<fpage>112</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.2174/18715273113126660130</pub-id>
<pub-id pub-id-type="other">2-s2.0-84896714050</pub-id>
<pub-id pub-id-type="pmid">24040810</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cross-national epidemiology of DSM-IV major depressive episode</article-title>
<source/>
<italic toggle="yes">BMC Medicine</italic>
<year>2011</year>
<volume>9</volume>
<issue>1</issue>
<fpage>p. 90</fpage>
<pub-id pub-id-type="doi">10.1186/1741-7015-9-90</pub-id>
<pub-id pub-id-type="other">2-s2.0-79960659664</pub-id>
<pub-id pub-id-type="pmid">21791035</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Psychomotor retardation and externally oriented thinking in major depression</article-title>
<source/>
<italic toggle="yes">Neuropsychiatric Disease and Treatment</italic>
<year>2013</year>
<volume>9</volume>
<fpage>759</fpage>
<lpage>766</lpage>
<pub-id pub-id-type="doi">10.2147/NDT.S44650</pub-id>
<pub-id pub-id-type="other">2-s2.0-84878390804</pub-id>
<pub-id pub-id-type="pmid">23745046</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="book">
<collab>American Psychiatric Association</collab>
<source/>
<italic toggle="yes">Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)</italic>
<year>2013</year>
<publisher-loc>Arlington, VA, USA</publisher-loc>
<publisher-name>American Psychiatric Association</publisher-name>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghanean</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ceniti</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>S. H.</given-names>
</name>
</person-group>
<article-title>Fatigue in patients with major depressive disorder: prevalence, burden and pharmacological approaches to management</article-title>
<source/>
<italic toggle="yes">CNS Drugs</italic>
<year>2018</year>
<volume>32</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1007/s40263-018-0490-z</pub-id>
<pub-id pub-id-type="other">2-s2.0-85041205979</pub-id>
<pub-id pub-id-type="pmid">29383573</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Calandra</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Accelerated aging in major depression: the role of nitro-oxidative stress</article-title>
<source/>
<italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic>
<year>2013</year>
<volume>2013</volume>
<fpage>6</fpage>
<pub-id pub-id-type="publisher-id">230797</pub-id>
<pub-id pub-id-type="doi">10.1155/2013/230797</pub-id>
<pub-id pub-id-type="other">2-s2.0-84890077717</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dowlati</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Swardfager</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A meta-analysis of cytokines in major depression</article-title>
<source/>
<italic toggle="yes">Biological Psychiatry</italic>
<year>2010</year>
<volume>67</volume>
<issue>5</issue>
<fpage>446</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.033</pub-id>
<pub-id pub-id-type="other">2-s2.0-75849155537</pub-id>
<pub-id pub-id-type="pmid">20015486</pub-id>
</element-citation>
</ref>
<ref id="B72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sluzewska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rybakowski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bosmans</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Indicators of immune activation in major depression</article-title>
<source/>
<italic toggle="yes">Psychiatry Research</italic>
<year>1996</year>
<volume>64</volume>
<issue>3</issue>
<fpage>161</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-1781(96)02783-7</pub-id>
<pub-id pub-id-type="other">2-s2.0-0030590636</pub-id>
<pub-id pub-id-type="pmid">8944394</pub-id>
</element-citation>
</ref>
<ref id="B73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kubera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leunis</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Geffard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bosmans</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&amp;NS), and autoimmune responses directed against O&amp;NS-damaged neoepitopes</article-title>
<source/>
<italic toggle="yes">Acta Psychiatrica Scandinavica</italic>
<year>2013</year>
<volume>127</volume>
<issue>5</issue>
<fpage>344</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0447.2012.01908.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-84875300745</pub-id>
<pub-id pub-id-type="pmid">22900942</pub-id>
</element-citation>
</ref>
<ref id="B74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leonard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression</article-title>
<source/>
<italic toggle="yes">Neuroscience and Biobehavioral Reviews</italic>
<year>2012</year>
<volume>36</volume>
<issue>2</issue>
<fpage>764</fpage>
<lpage>785</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2011.12.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-84855801183</pub-id>
<pub-id pub-id-type="pmid">22197082</pub-id>
</element-citation>
</ref>
<ref id="B75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications</article-title>
<source/>
<italic toggle="yes">Current Pharmaceutical Design</italic>
<year>2014</year>
<volume>20</volume>
<issue>23</issue>
<fpage>3812</fpage>
<lpage>3847</lpage>
<pub-id pub-id-type="doi">10.2174/13816128113196660738</pub-id>
<pub-id pub-id-type="other">2-s2.0-84896725752</pub-id>
<pub-id pub-id-type="pmid">24180395</pub-id>
</element-citation>
</ref>
<ref id="B76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of intestinal microbiota on exercise performance in mice</article-title>
<source/>
<italic toggle="yes">Journal of Strength and Conditioning Research</italic>
<year>2015</year>
<volume>29</volume>
<issue>2</issue>
<fpage>552</fpage>
<lpage>558</lpage>
<pub-id pub-id-type="doi">10.1519/JSC.0000000000000644</pub-id>
<pub-id pub-id-type="other">2-s2.0-84925959569</pub-id>
<pub-id pub-id-type="pmid">25144131</pub-id>
</element-citation>
</ref>
<ref id="B77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Amao</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of intestinal microflora on superoxide dismutase activity in the mouse cecum</article-title>
<source/>
<italic toggle="yes">Experimental Animals</italic>
<year>2011</year>
<volume>60</volume>
<issue>2</issue>
<fpage>133</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1538/expanim.60.133</pub-id>
<pub-id pub-id-type="other">2-s2.0-79955366067</pub-id>
<pub-id pub-id-type="pmid">21512268</pub-id>
</element-citation>
</ref>
<ref id="B78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>W. N.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. M.</given-names>
</name>
</person-group>
<article-title>Regulation of cyclooxygenase-2 and cytosolic phospholipase A2 gene expression by lipopolysaccharide through the RNA-binding protein HuR: involvement of NADPH oxidase, reactive oxygen species and mitogen-activated protein kinases</article-title>
<source/>
<italic toggle="yes">British Journal of Pharmacology</italic>
<year>2011</year>
<volume>163</volume>
<issue>8</issue>
<fpage>1691</fpage>
<lpage>1706</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.2011.01312.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-79960919004</pub-id>
<pub-id pub-id-type="pmid">21391979</pub-id>
</element-citation>
</ref>
<ref id="B79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Riches</surname>
<given-names>D. W. H.</given-names>
</name>
</person-group>
<article-title>IFN-<italic>γ</italic> + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38<italic><sup>mapk</sup></italic> in a mouse macrophage cell line</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology. Cell Physiology</italic>
<year>2001</year>
<volume>280</volume>
<issue>3</issue>
<fpage>C441</fpage>
<lpage>C450</lpage>
<pub-id pub-id-type="doi">10.1152/ajpcell.2001.280.3.C441</pub-id>
<pub-id pub-id-type="pmid">11171562</pub-id>
</element-citation>
</ref>
<ref id="B80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaster</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Budni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gazal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>A. R. S.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>A. L. S.</given-names>
</name>
</person-group>
<article-title>The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors</article-title>
<source/>
<italic toggle="yes">Purinergic Signal</italic>
<year>2013</year>
<volume>9</volume>
<issue>3</issue>
<fpage>481</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1007/s11302-013-9361-8</pub-id>
<pub-id pub-id-type="other">2-s2.0-84883447161</pub-id>
<pub-id pub-id-type="pmid">23613131</pub-id>
</element-citation>
</ref>
<ref id="B81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelly</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Borre</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>O' Brien</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat</article-title>
<source/>
<italic toggle="yes">Journal of Psychiatric Research</italic>
<year>2016</year>
<volume>82</volume>
<fpage>109</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.07.019</pub-id>
<pub-id pub-id-type="other">2-s2.0-84979955472</pub-id>
<pub-id pub-id-type="pmid">27491067</pub-id>
</element-citation>
</ref>
<ref id="B82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kubera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leunis</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut</article-title>
<source/>
<italic toggle="yes">Journal of Affective Disorders</italic>
<year>2012</year>
<volume>141</volume>
<issue>1</issue>
<fpage>55</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2012.02.023</pub-id>
<pub-id pub-id-type="other">2-s2.0-84865528173</pub-id>
<pub-id pub-id-type="pmid">22410503</pub-id>
</element-citation>
</ref>
<ref id="B83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calderwood</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Murshid</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Extracellular HSPs: the complicated roles of extracellular HSPs in immunity</article-title>
<source/>
<italic toggle="yes">Frontiers in Immunology</italic>
<year>2016</year>
<volume>7</volume>
<fpage>p. 159</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2016.00159</pub-id>
<pub-id pub-id-type="other">2-s2.0-84966702482</pub-id>
</element-citation>
</ref>
<ref id="B84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borges</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Bonorino</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Modulation of alloimmunity by heat shock proteins</article-title>
<source/>
<italic toggle="yes">Frontiers in Immunology</italic>
<year>2016</year>
<volume>7</volume>
<fpage>p. 303</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2016.00303</pub-id>
<pub-id pub-id-type="other">2-s2.0-84989329175</pub-id>
</element-citation>
</ref>
<ref id="B85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasquali</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Harlow</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>C. N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women</article-title>
<source/>
<italic toggle="yes">European Archives of Psychiatry and Clinical Neuroscience</italic>
<year>2018</year>
<volume>268</volume>
<issue>8</issue>
<fpage>771</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-017-0812-z</pub-id>
<pub-id pub-id-type="other">2-s2.0-85019715695</pub-id>
<pub-id pub-id-type="pmid">28550365</pub-id>
</element-citation>
</ref>
<ref id="B86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnal</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Lallès</surname>
<given-names>J. P.</given-names>
</name>
</person-group>
<article-title>Gut epithelial inducible heat-shock proteins and their modulation by diet and the microbiota</article-title>
<source/>
<italic toggle="yes">Nutrition Reviews</italic>
<year>2016</year>
<volume>74</volume>
<issue>3</issue>
<fpage>181</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1093/nutrit/nuv104</pub-id>
<pub-id pub-id-type="other">2-s2.0-84964203207</pub-id>
<pub-id pub-id-type="pmid">26883882</pub-id>
</element-citation>
</ref>
<ref id="B87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tannock</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Savage</surname>
<given-names>D. C.</given-names>
</name>
</person-group>
<article-title>Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract</article-title>
<source/>
<italic toggle="yes">Infection and Immunity</italic>
<year>1974</year>
<volume>9</volume>
<issue>3</issue>
<fpage>591</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="pmid">4593471</pub-id>
</element-citation>
</ref>
<ref id="B88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naseribafrouei</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hestad</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Avershina</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Correlation between the human fecal microbiota and depression</article-title>
<source/>
<italic toggle="yes">Neurogastroenterology and Motility</italic>
<year>2014</year>
<volume>26</volume>
<issue>8</issue>
<fpage>1155</fpage>
<lpage>1162</lpage>
<pub-id pub-id-type="doi">10.1111/nmo.12378</pub-id>
<pub-id pub-id-type="other">2-s2.0-84904411548</pub-id>
<pub-id pub-id-type="pmid">24888394</pub-id>
</element-citation>
</ref>
<ref id="B89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>
<source/>
<italic toggle="yes">The Journal of Physiology</italic>
<year>2004</year>
<volume>558</volume>
<issue>1</issue>
<fpage>263</fpage>
<lpage>275</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id>
<pub-id pub-id-type="other">2-s2.0-4043161248</pub-id>
<pub-id pub-id-type="pmid">15133062</pub-id>
</element-citation>
</ref>
<ref id="B90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Talaei</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Alaei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Salami</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis</article-title>
<source/>
<italic toggle="yes">Neuroscience</italic>
<year>2013</year>
<volume>240</volume>
<fpage>287</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.02.055</pub-id>
<pub-id pub-id-type="other">2-s2.0-84876404010</pub-id>
<pub-id pub-id-type="pmid">23500100</pub-id>
</element-citation>
</ref>
<ref id="B91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bambling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vitetta</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested</article-title>
<source/>
<italic toggle="yes">Inflammopharmacology</italic>
<year>2017</year>
<volume>25</volume>
<issue>2</issue>
<fpage>271</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1007/s10787-017-0311-x</pub-id>
<pub-id pub-id-type="other">2-s2.0-85011604884</pub-id>
<pub-id pub-id-type="pmid">28155119</pub-id>
</element-citation>
</ref>
<ref id="B92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akkasheh</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kashani-Poor</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tajabadi-Ebrahimi</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial</article-title>
<source/>
<italic toggle="yes">Nutrition</italic>
<year>2016</year>
<volume>32</volume>
<issue>3</issue>
<fpage>315</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2015.09.003</pub-id>
<pub-id pub-id-type="other">2-s2.0-84961202243</pub-id>
<pub-id pub-id-type="pmid">26706022</pub-id>
</element-citation>
</ref>
<ref id="B93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romijn</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Rucklidge</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Kuijer</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Frampton</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression</article-title>
<source/>
<italic toggle="yes">The Australian and New Zealand Journal of Psychiatry</italic>
<year>2017</year>
<volume>51</volume>
<issue>8</issue>
<fpage>810</fpage>
<lpage>821</lpage>
<pub-id pub-id-type="doi">10.1177/0004867416686694</pub-id>
<pub-id pub-id-type="other">2-s2.0-85021710126</pub-id>
<pub-id pub-id-type="pmid">28068788</pub-id>
</element-citation>
</ref>
<ref id="B94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smyth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Diabetes and obesity: the twin epidemics</article-title>
<source/>
<italic toggle="yes">Nature Medicine</italic>
<year>2006</year>
<volume>12</volume>
<issue>1</issue>
<fpage>75</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1038/nm0106-75</pub-id>
<pub-id pub-id-type="other">2-s2.0-30044443649</pub-id>
</element-citation>
</ref>
<ref id="B95">
<label>95</label>
<element-citation publication-type="book">
<collab>World Health Organization</collab>
<source/>
<italic toggle="yes">Global Report on Diabetes</italic>
<year>2016</year>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/diabetes/publications/grd-2016/en/">http://www.who.int/diabetes/publications/grd-2016/en/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="B96">
<label>96</label>
<element-citation publication-type="book">
<collab>World Health Organization</collab>
<source/>
<italic toggle="yes">Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016</italic>
<year>2018</year>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/healthinfo/global_burden_disease/estimates/en/">http://www.who.int/healthinfo/global_burden_disease/estimates/en/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="B97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathers</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Loncar</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Projections of global mortality and burden of disease from 2002 to 2030</article-title>
<source/>
<italic toggle="yes">PLoS Medicine</italic>
<year>2006</year>
<volume>3</volume>
<issue>11, article e442</issue>
<pub-id pub-id-type="doi">10.1371/journal.pmed.0030442</pub-id>
<pub-id pub-id-type="other">2-s2.0-33845338724</pub-id>
<pub-id pub-id-type="pmid">17132052</pub-id>
</element-citation>
</ref>
<ref id="B98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lozupone</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group>
<article-title>Obesity alters gut microbial ecology</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2005</year>
<volume>102</volume>
<issue>31</issue>
<fpage>11070</fpage>
<lpage>11075</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0504978102</pub-id>
<pub-id pub-id-type="other">2-s2.0-23344442120</pub-id>
<pub-id pub-id-type="pmid">16033867</pub-id>
</element-citation>
</ref>
<ref id="B99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backhed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota as an environmental factor that regulates fat storage</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2004</year>
<volume>101</volume>
<issue>44</issue>
<fpage>15718</fpage>
<lpage>15723</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0407076101</pub-id>
<pub-id pub-id-type="other">2-s2.0-8144226856</pub-id>
<pub-id pub-id-type="pmid">15505215</pub-id>
</element-citation>
</ref>
<ref id="B100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Festi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schiumerini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Eusebi</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Marasco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Taddia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Colecchia</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Gut microbiota and metabolic syndrome</article-title>
<source/>
<italic toggle="yes">World Journal of Gastroenterology</italic>
<year>2014</year>
<volume>20</volume>
<issue>43</issue>
<fpage>16079</fpage>
<lpage>16094</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i43.16079</pub-id>
<pub-id pub-id-type="other">2-s2.0-84912544732</pub-id>
<pub-id pub-id-type="pmid">25473159</pub-id>
</element-citation>
</ref>
<ref id="B101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moschen</surname>
<given-names>A. R.</given-names>
</name>
</person-group>
<article-title>Microbiota and diabetes: an evolving relationship</article-title>
<source/>
<italic toggle="yes">Gut</italic>
<year>2014</year>
<volume>63</volume>
<issue>9</issue>
<fpage>1513</fpage>
<lpage>1521</lpage>
<pub-id pub-id-type="doi">10.1136/gutjnl-2014-306928</pub-id>
<pub-id pub-id-type="other">2-s2.0-84905586295</pub-id>
<pub-id pub-id-type="pmid">24833634</pub-id>
</element-citation>
</ref>
<ref id="B102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bäckhed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Sonnenburg</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group>
<article-title>Host-bacterial mutualism in the human intestine</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2005</year>
<volume>307</volume>
<issue>5717</issue>
<fpage>1915</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="doi">10.1126/science.1104816</pub-id>
<pub-id pub-id-type="other">2-s2.0-15544369658</pub-id>
<pub-id pub-id-type="pmid">15790844</pub-id>
</element-citation>
</ref>
<ref id="B103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dethlefsen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eckburg</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Bik</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Relman</surname>
<given-names>D. A.</given-names>
</name>
</person-group>
<article-title>Assembly of the human intestinal microbiota</article-title>
<source/>
<italic toggle="yes">Trends in Ecology &amp; Evolution</italic>
<year>2006</year>
<volume>21</volume>
<issue>9</issue>
<fpage>517</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1016/j.tree.2006.06.013</pub-id>
<pub-id pub-id-type="other">2-s2.0-33747177087</pub-id>
<pub-id pub-id-type="pmid">16820245</pub-id>
</element-citation>
</ref>
<ref id="B104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajilic-Stojanovic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>W. M.</given-names>
</name>
</person-group>
<article-title>The first 1000 cultured species of the human gastrointestinal microbiota</article-title>
<source/>
<italic toggle="yes">FEMS Microbiology Reviews</italic>
<year>2014</year>
<volume>38</volume>
<issue>5</issue>
<fpage>996</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="doi">10.1111/1574-6976.12075</pub-id>
<pub-id pub-id-type="other">2-s2.0-84927692256</pub-id>
<pub-id pub-id-type="pmid">24861948</pub-id>
</element-citation>
</ref>
<ref id="B105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graf</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>di Cagno</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fåk</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of diet to the composition of the human gut microbiota</article-title>
<source/>
<italic toggle="yes">Microbial Ecology in Health and Disease</italic>
<year>2015</year>
<volume>26</volume>
<pub-id pub-id-type="doi">10.3402/mehd.v26.26164</pub-id>
</element-citation>
</ref>
<ref id="B106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Luca</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Olefsky</surname>
<given-names>J. M.</given-names>
</name>
</person-group>
<article-title>Inflammation and insulin resistance</article-title>
<source/>
<italic toggle="yes">FEBS Letters</italic>
<year>2008</year>
<volume>582</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2007.11.057</pub-id>
<pub-id pub-id-type="other">2-s2.0-37549022688</pub-id>
<pub-id pub-id-type="pmid">18053812</pub-id>
</element-citation>
</ref>
<ref id="B107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridaura</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Faith</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>F. E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota from twins discordant for obesity modulate metabolism in mice</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2013</year>
<volume>341</volume>
<issue>6150, article 1241214</issue>
<pub-id pub-id-type="doi">10.1126/science.1241214</pub-id>
<pub-id pub-id-type="other">2-s2.0-84883478660</pub-id>
<pub-id pub-id-type="pmid">24009397</pub-id>
</element-citation>
</ref>
<ref id="B108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MetaHIT consortium</surname>
</name>
<name>
<surname>le Chatelier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2013</year>
<volume>500</volume>
<issue>7464</issue>
<fpage>541</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.1038/nature12506</pub-id>
<pub-id pub-id-type="other">2-s2.0-84883110880</pub-id>
<pub-id pub-id-type="pmid">23985870</pub-id>
</element-citation>
</ref>
<ref id="B109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakraborti</surname>
<given-names>C. K.</given-names>
</name>
</person-group>
<article-title>New-found link between microbiota and obesity</article-title>
<source/>
<italic toggle="yes">World Journal of Gastrointestinal Pathophysiology</italic>
<year>2015</year>
<volume>6</volume>
<issue>4</issue>
<fpage>110</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.4291/wjgp.v6.i4.110</pub-id>
<pub-id pub-id-type="pmid">26600968</pub-id>
</element-citation>
</ref>
<ref id="B110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Magrini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mardis</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2006</year>
<volume>444</volume>
<issue>7122</issue>
<fpage>1027</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="doi">10.1038/nature05414</pub-id>
<pub-id pub-id-type="other">2-s2.0-33845874101</pub-id>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="B111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2012</year>
<volume>490</volume>
<issue>7418</issue>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1038/nature11450</pub-id>
<pub-id pub-id-type="other">2-s2.0-84867074831</pub-id>
<pub-id pub-id-type="pmid">23023125</pub-id>
</element-citation>
</ref>
<ref id="B112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cani</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Amar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>M. A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic endotoxemia initiates obesity and insulin resistance</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2007</year>
<volume>56</volume>
<issue>7</issue>
<fpage>1761</fpage>
<lpage>1772</lpage>
<pub-id pub-id-type="doi">10.2337/db06-1491</pub-id>
<pub-id pub-id-type="other">2-s2.0-34347399563</pub-id>
<pub-id pub-id-type="pmid">17456850</pub-id>
</element-citation>
</ref>
<ref id="B113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jialal</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rajamani</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Endotoxemia of metabolic syndrome: a pivotal mediator of meta-inflammation</article-title>
<source/>
<italic toggle="yes">Metabolic Syndrome and Related Disorders</italic>
<year>2014</year>
<volume>12</volume>
<issue>9</issue>
<fpage>454</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1089/met.2014.1504</pub-id>
<pub-id pub-id-type="other">2-s2.0-84931457617</pub-id>
<pub-id pub-id-type="pmid">25162769</pub-id>
</element-citation>
</ref>
<ref id="B114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Creely</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>McTernan</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Kusminski</surname>
<given-names>C. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology. Endocrinology and Metabolism</italic>
<year>2007</year>
<volume>292</volume>
<issue>3</issue>
<fpage>E740</fpage>
<lpage>E747</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00302.2006</pub-id>
<pub-id pub-id-type="other">2-s2.0-33947182436</pub-id>
<pub-id pub-id-type="pmid">17090751</pub-id>
</element-citation>
</ref>
<ref id="B115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cani</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Bibiloni</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Knauf</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2008</year>
<volume>57</volume>
<issue>6</issue>
<fpage>1470</fpage>
<lpage>1481</lpage>
<pub-id pub-id-type="doi">10.2337/db07-1403</pub-id>
<pub-id pub-id-type="other">2-s2.0-48249125862</pub-id>
<pub-id pub-id-type="pmid">18305141</pub-id>
</element-citation>
</ref>
<ref id="B116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobyliak</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Conte</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cammarota</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Probiotics in prevention and treatment of obesity: a critical view</article-title>
<source/>
<italic toggle="yes">Nutrition &amp; Metabolism</italic>
<year>2016</year>
<volume>13</volume>
<issue>1</issue>
<fpage>p. 14</fpage>
<pub-id pub-id-type="doi">10.1186/s12986-016-0067-0</pub-id>
<pub-id pub-id-type="other">2-s2.0-84959019280</pub-id>
<pub-id pub-id-type="pmid">26900391</pub-id>
</element-citation>
</ref>
<ref id="B117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblhuber</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schuetz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gostner</surname>
<given-names>J. M.</given-names>
</name>
</person-group>
<article-title>Probiotic supplementation in patients with Alzheimer’s dementia-an explorative intervention study</article-title>
<source/>
<italic toggle="yes">Current Alzheimer Research</italic>
<year>2018</year>
<volume>15</volume>
<issue>12</issue>
<fpage>1106</fpage>
<lpage>1113</lpage>
<pub-id pub-id-type="doi">10.2174/1389200219666180813144834</pub-id>
<pub-id pub-id-type="other">2-s2.0-85054370813</pub-id>
<pub-id pub-id-type="pmid">30101706</pub-id>
</element-citation>
</ref>
<ref id="B118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Firouzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Majid</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kamaruddin</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Barakatun-Nisak</surname>
<given-names>M. Y.</given-names>
</name>
</person-group>
<article-title>Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial</article-title>
<source/>
<italic toggle="yes">European Journal of Nutrition</italic>
<year>2017</year>
<volume>56</volume>
<issue>4</issue>
<fpage>1535</fpage>
<lpage>1550</lpage>
<pub-id pub-id-type="doi">10.1007/s00394-016-1199-8</pub-id>
<pub-id pub-id-type="other">2-s2.0-84961197300</pub-id>
<pub-id pub-id-type="pmid">26988693</pub-id>
</element-citation>
</ref>
<ref id="B119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirbaglou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Stearns</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Motamed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ritvo</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials</article-title>
<source/>
<italic toggle="yes">Nutrition Research</italic>
<year>2016</year>
<volume>36</volume>
<issue>9</issue>
<fpage>889</fpage>
<lpage>898</lpage>
<pub-id pub-id-type="doi">10.1016/j.nutres.2016.06.009</pub-id>
<pub-id pub-id-type="other">2-s2.0-84981200539</pub-id>
<pub-id pub-id-type="pmid">27632908</pub-id>
</element-citation>
</ref>
<ref id="B120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luca</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Gut microbiota and depression: just a fashionable topic?</article-title>
<source/>
<italic toggle="yes">Journal of Depression and Anxiety Forecas</italic>
<year>2018</year>
<volume>1</volume>
<issue>1</issue>
<fpage>p. 1008</fpage>
</element-citation>
</ref>
<ref id="B121">
<label>121</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Rosenblat</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Mansur</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Baskaran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McIntyre</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Sartorius</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>R. I. G.</given-names>
</name>
<name>
<surname>Maj</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Depression, diabetes and dementia</article-title>
<source/>
<italic toggle="yes">Comorbidity of Mental and Physical Disorders</italic>
<year>2015</year>
<volume>179</volume>
<publisher-loc>Basel</publisher-loc>
<publisher-name>Karger</publisher-name>
<fpage>42</fpage>
<lpage>53</lpage>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Dysbiosis favors oxidative stress and affects the immunological and inflammatory status of the host. NO: nitric oxide; OS: oxidative stress; ROS: reactive oxygen species.</p>
</caption>
<graphic xlink:href="OMCL2019-4730539.001"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>